Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 5, 2025Frontiers in OncologyOpen Access

Bibliometric analysis of immunotherapy for esophageal cancer: 2004-2024

View Full Paper
Ask AI
Bookmark
Share

Authors

YHYunqi HuaYLYubo LiuYLYanhong Liu

Discussion

Loading...

Member takes

Overview

Bibliometric analysis reveals evolving trends and key contributors in immunotherapy for esophageal cancer.

Key Points

  • The study finds a steady increase in publications on immunotherapy for esophageal cancer.
  • China emerges as the leading contributor, with Zhengzhou University being the most productive institution.
  • Immunotherapy is increasingly focusing on tumor microenvironment and immune checkpoint inhibitors.
  • The research emphasizes multimodal treatment strategies to enhance patient outcomes.

Cite This Study

Hua et al. (2025) studied this question.

synapsesocial.com/papers/68c23a2cb210217d6477f185https://doi.org/10.3389/fonc.2025.1565132
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploring research trends in cancer immunotherapy via single-cell technologies: a scientometric perspective2025
  2. 2Research Progress on Neoadjuvant Immunotherapy in Esophageal Squamous Cell Carcinoma2025
  3. 3Scientometric study on esophageal cancer and hot beverages/food: emerging patterns, collaboration, and impact2025
  4. 4Treatment efficacy of first-line immunotherapy in advanced esophageal small cell carcinoma: A real-world retrospective study2025
  5. 5Analysis of the safety and efficacy of PD-1/PD-L1 inhibitors combined with chemotherapy in the treatment of locally advanced resectable esophageal squamous cell carcinoma: a systematic review and meta-analysis based on four randomized controlled trials2025